Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
SEC-verified vehicles of the same sponsor, predating these roles and carrying none of them. The badge counts them; the figure beside this one does not.
Mergers closed across all 4 — these vehicles and the franchise's earlier ones together.
Announced but not closed, and still hunting — again over all 4.
No closed vehicle here has both a stored price and a filed trust value to score it against.
3 vehicles on file, newest listing first
5 of 9 appear on more than one
5 people on two or more of them
Nicholas Fernandez is a seasoned financial executive and Certified Public Accountant currently serving as the Chief Financial Officer of Amanat Acquisition Corp. (NASDAQ: AMAN), a role he assumed in January 2026. In this capacity, he helped lead the special purpose acquisition company’s $75 million initial public offering in May 2026, which priced 7.5 million Class A ordinary shares at $10.00 each. Amanat Acquisition Corp. is focused on pursuing business combinations in the healthcare or healthcare-related industries, leveraging Fernandez’s extensive financial and operational expertise. In addition to his role at Amanat, Fernandez concurrently serves as the Chief Financial Officer of JATT II Acquisition Corp., another blank-check company targeting healthcare and life sciences businesses, particularly those utilizing data-driven approaches like machine learning and computational biology. He is also a Board Member of Liminatus Pharma, Inc., a position he has held since April 2025 following its business combination with Iris Acquisition Corp.
Throughout his career, Fernandez has amassed over 20 years of experience across operations, accounting, and finance, with a strong emphasis on the alternative investment sector. Prior to his current SPAC roles, he served as the Chief Operating Officer and Chief Financial Officer of Athanor Capital, a hedge fund, from December 2019 to December 2025. During his tenure at Athanor, he chaired the Valuation Committee and sat on the Management Committee. From April 2024 to November 2024, he held the roles of COO, CFO, and Chief Compliance Officer at EcoBridge Capital Management, LP, a private equity climate fund. Previously, Fernandez was the Chief Financial Officer of the Asset Management and Alternative Investments Divisions at Jefferies LLC, a global bulge bracket investment bank, from February 2017 to April 2019. His earlier career included various positions at alternative investment managers, where he progressed from a Fund Accountant to a Controller/Director of Operations. He began his career in public accounting with Ernst & Young in their Financial Services Office in New York, focusing on hedge, private equity, and venture funds.
Fernandez’s track record in the SPAC space includes serving as an Independent Director of Iris Acquisition Corp from May 2023 until its business combination with Liminatus Pharma, LLC in April 2025, after which he transitioned to the board of the post-combination company, Liminatus Pharma, Inc. He holds a Bachelor of Science in Accounting and Finance with a minor in Business Administration from the University at Albany, SUNY, and maintains an active CPA license in the state of New York. At 42 years old, Fernandez is based in Westfield, New Jersey, and continues to be an active leader in the SPAC and alternative investment landscapes.
This record is keyed to SEC CIK 0001978036 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 21 institutional-holder rows on these vehicles, under 13 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.